Corn allergy
Allergy Food Testing With Skin Testing
-
Probiotics may help prevent allergies - Times of India
LONDON: A new study has found that if pregnant mothers and infants are exposed to probiotic bacteria, it can result in triggering the growth of the immune system, and thus lead to prevention of allergies. When one takes a dose of antibiotics
Source: timesofindia.indiatimes.com
FDA rejects application for allergy drug - Chicago Sun-Times
KENILWORTH, N.J.—- The Food and Drug Administration has turned down an application by two drugmakers to produce an allergy drug combining the active ingredients of their popular Claritin and Singulair tablets. Schering-Plough/Merck Pharmaceuticals
Source: www.suntimes.com
Allergy Season Warning Comes With a Ring Tone - Forbes
LYNDHURST, N.J., April 24 /PRNewswire-FirstCall/ — Seasonal allergies bloom together with plants and flowers, but some everyday devices like cell phones and iPods that have become synonymous with modern living may also be the cause of allergic
Source: www.forbes.com
FDA rejects Schering-Merck combo allergy drug - Guardian Unlimited
NEW YORK, April 25 (Reuters) - Drugmakers Schering-Plough Corp and Merck & Co said on Friday the U.S. Food and Drug Administration rejected a proposed asthma-allergy drug that would have combined two best-selling drugs, Claritin and Singulair, into
Source: www.guardian.co.uk
FDA turns down application for combo allergy drug - Miami Herald
The Food and Drug Administration has turned down an application by two drugmakers to produce an allergy drug combining the active ingredients of their popular Claritin and Singulair tablets. Schering-Plough/Merck Pharmaceuticals, a joint venture of
Source: www.miamiherald.com
The Worst Spring Allergy City Is - CBS News
Greensboro, N.C., takes second place, followed by Johnson City, Tenn., Augusta, Ga., and Jackson, Miss. in fifth place. The annual list is based on four factors: allergy prevalence, seasonal pollen, allergy medication use per patient, and the number
Source: www.cbsnews.com
FDA rejects Schering-Plough, Merck combo allergy drug - Guardian Unlimited
NEW YORK, April 25 (Reuters) - Drugmakers Schering-Plough Corp and Merck & Co said the U.S. Food and Drug Administration rejected a proposed allergy/rhinitis drug that would have combined two best-selling drugs, Claritin and Singulair into one tablet
Source: www.guardian.co.uk
India’s Ranbaxy receives US FDA approval to make, market allergy drug - CNBC
MUMBAI (Thomson Financial) - India-based Ranbaxy Laboratories Ltd. said it has received final approval from the U.S. Food and Drug Administration (FDA) to manufacture and market Cetirizine hydrochloride oral solution used in the treatment of
Source: www.cnbc.com